M. H. Abdul-Aziz Et Al. , "Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort," JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.71, no.1, pp.196-207, 2016
Abdul-Aziz, M. H. Et Al. 2016. Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.71, no.1 , 196-207.
Abdul-Aziz, M. H., Lipman, J., AKOVA, M., Bassetti, M., De Waele, J. J., Dimopoulos, G., ... Dulhunty, J.(2016). Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.71, no.1, 196-207.
Abdul-Aziz, Mohd Et Al. "Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort," JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.71, no.1, 196-207, 2016
Abdul-Aziz, Mohd H. Et Al. "Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort." JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.71, no.1, pp.196-207, 2016
Abdul-Aziz, M. H. Et Al. (2016) . "Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort." JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.71, no.1, pp.196-207.
@article{article, author={Mohd H. Abdul-Aziz Et Al. }, title={Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort}, journal={JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY}, year=2016, pages={196-207} }